ACP5 and idiopathic pulmonary fibrosis: Taken together, our results not only provide insights into the understanding of IPF pathogenesis but also strongly suggest that strategies aimed at silencing or suppressing ACP5 could be viable approaches for the treatment of pulmonary fibrosis in clinical settings.